Heart Disease Trial, Recruiting NCT06827314 Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06827314
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who are admitted to a participating cardiac intensive care unit with suspected cardiogenic shock (a serious condition where the heart cannot pump enough blood) classified as a moderate to severe stage (stages C through E on a standard medical scale).
  • People who have signed a form giving their informed consent to participate.

Who may not be able to join:

  • People whose cardiogenic shock developed as a result of heart surgery (sometimes called post-cardiotomy shock).
  • People who have serious injuries to multiple parts of the body, or a significant brain or nervous system injury.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Luciano G Potena, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phone: 0512143725

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Registry
ClinicalTrials.gov
Start date
6 December 2022
Est. completion
1 November 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Incidence of CS over the total CICU admissions stratified by aetiologies, sex and age.; Length of hospitalization, stratified by aetiologies, sex and age.; CS-related in-hospital mortality stratified by aetiologies, sex and age.; Epidemiology of patients admitted with CS, regarding age, gender, etiology and modality of presentation (acute or acute on chronic), echocardiographic and haemodynamic data, treatment strategy with inotropes and/or short-term MCS, cardiac arrest.; Recovery from cardiogenic shock, defined as improvement to at least SCAI stage B or discharge from CICU to a step-down war...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov